[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100408097":3},{"organization":4,"armGroups":7,"interventions":20,"overallOfficials":26,"centralContacts":30,"locations":36,"responsibleParty":53,"collaborators":26,"id":55,"slug":26,"hasResults":56,"nctId":57,"briefTitle":58,"officialTitle":59,"acronym":26,"eligibilityCriteria":60,"healthyVolunteers":56,"sex":61,"minAge":62,"maxAge":63,"enrollmentInfo":64,"targetDuration":26,"studyType":67,"phases":68,"briefSummary":70,"conditions":71,"keywords":73,"overallStatus":39,"whyStopped":26,"lastUpdateSubmitDate":75,"lastUpdatePostDateStruct":76,"startDateStruct":79,"completionDateStruct":81,"leadSponsor":83,"locationsCount":84},{"fullName":5,"class":6},"EMS","INDUSTRY",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"FINLÂNDIA","EXPERIMENTAL","The study is double-dummy. The patient must take 1 pill and apply hair lotion as follow:\n\n1 tablet finasteride placebo, oral, once a day.\n\n1 mL Finlândia hair lotion, topical, twice a day.",[13],"Drug: Finlândia Association + finasteride placebo",{"label":15,"type":16,"description":17,"interventionNames":18},"Minoxidil + finasteride","ACTIVE_COMPARATOR","The study is double-dummy. The patient must take 1 pill and apply hair lotion as follow:\n\n1 tablet finasteride, oral, once a day.\n\n1 mL minoxidil hair lotion, topical, twice a day.",[19],"Drug: Minoxidil + finasteride",[21,27],{"type":22,"name":23,"description":24,"armGroupLabels":25,"otherNames":26},"DRUG","Finlândia Association + finasteride placebo","Finlândia association hair lotion + finasteride placebo",[9],null,{"type":22,"name":15,"description":28,"armGroupLabels":29,"otherNames":26},"Minoxidil hair lotion + Finasteride 1 mg",[15],[31],{"name":32,"role":33,"phone":34,"phoneExt":26,"email":35},"Monalisa FB Oliveira, MD","CONTACT","+551938879851","pesquisa.clinica@ncfarma.com.br",[37],{"facility":38,"status":39,"city":40,"state":41,"zip":26,"country":42,"cosmosGeoPoint":43,"geoPoint":48,"contacts":49},"Medcin Instituto Da Pele","RECRUITING","Osasco","São Paulo","Brazil",{"type":44,"coordinates":45},"Point",[46,47],-46.79167,-23.5325,{"lat":47,"lon":46},[50],{"name":51,"role":33,"phone":52,"phoneExt":26,"email":26},"FLAVIA ADDOR","551136816362",{"type":54,"investigatorFullName":26,"investigatorTitle":26,"investigatorAffiliation":26,"oldNameTitle":26,"oldOrganization":26},"SPONSOR","100408097",false,"NCT04594018","Efficacy and Safety of Finlândia Hair Lotion Association on Androgenetic Alopecia","National, Multicentre, Randomized, Double-blind, Double-dummy Phase III Clinical Trial to Evaluate the Efficacy and Safety of Finlândia Hair Lotion Association in the Treatment of Androgenetic Alopecia.","Inclusion Criteria:\n\n* Ability to confirm voluntary participation and agree to all trial purposes by signing and dating the informed consent forms;\n* Men aged 18 years or over and less than or equal to 60 years with a diagnosis of Androgenetic Alopecia grades IIIv to IV in the modified Norwood-Hamilton classification, who have been using minoxidil 5% for at least 3 months and willing to maintain the same style, approximate length and hair color throughout the test.\n\nExclusion Criteria:\n\n* Known hypersensitivity to the formula components used during the clinical trial;\n* History of alcohol and\u002For substance abuse within 2 years;\n* Participants with other concomitant dermatological diseases on the scalp, except for mild seborrhoea dermatitis;\n* Participants with a history of surgical treatment for hair loss or shaved scalp;\n* Participants who used shampoo or topical solution containing ketoconazole, tar, selenium, threonine or steroids in the last 2 weeks;\n* Participants who used 5α reductase inhibitors, such as finasteride and dutasteride, in the last 12 months;\n* Participants using testosterone replacement therapy (TRT) or using testosterone-containing gel;\n* Participants who used micro-infusion of medications on the skin (MMP), microneedling or intradermotherapy on the scalp in the last 3 months;\n* Participants who have undergone radiation treatment for the scalp or chemotherapy in the past year;\n* Participants with diseases that can affect hair growth;\n* Participants with a current medical history of cancer and \u002F or cancer treatment in the last 5 years;","MALE","18 Years","60 Years",{"count":65,"type":66},190,"ESTIMATED","INTERVENTIONAL",[69],"PHASE3","The purpose of this study is to evaluate the efficacy of Finlândia hair lotion association in the treatment of androgenetic alopecia.",[72],"Androgenetic Alopecia",[74],"androgenetic alopecia","2025-12-01",{"date":77,"type":78},"2025-12-08","ACTUAL",{"date":80,"type":78},"2023-02-02",{"date":82,"type":66},"2027-09",{"name":5,"class":6},1]